Department of Orthopaedic Surgery, Emory University, Atlanta, Georgia, USA.
Am J Sports Med. 2020 Nov;48(13):3339-3346. doi: 10.1177/0363546520960122. Epub 2020 Oct 8.
Studies have shown preoperative opioid use to influence outcomes after various surgical procedures. Researchers have not assessed this relationship after rotator cuff repair (RCR).
HYPOTHESIS/PURPOSE: The purpose was to assess the relationship between preoperative opioid use and outcomes after arthroscopic RCR. We hypothesized that patients prescribed higher daily averages of preoperative oral morphine equivalents (OMEs) would show increased rates of 90-day complications and 3-year revision surgery.
Cohort study; Level of evidence, 3.
The MarketScan claims database was utilized to identify patients who underwent arthroscopic RCR between 2009 and 2018. We used preoperative opioid use status to divide patients into groups based on the average daily OMEs consumed in the 6 months before surgery: opioid-naïve, <1, 1-<5, 5-<10, and ≥10 OMEs per day. We retrieved 90-day complication and 3-year revision surgery rates. Opioid use groups were then compared with binomial logistic regression and generalized linear models.
We identified 214,283 patients. Of those patients, 50.7% did not receive any preoperative opioids, while 7.7%, 26.8%, 6.3%, and 8.6% received <1, 1-<5, 5-<10, and ≥10 OMEs per day over a 6-month time period, respectively. Complications increased with increasing preoperative OMEs. Multivariate analysis revealed that any patient using ≥1 OME per day had increased rates of 3-year revision surgery, reoperations, and infections. Specifically, patients averaging ≥10 OMEs per day showed a 103% (odds ratio, 2.03 [95% CI, 1.62-2.54]; < .001) increase in the odds of revision surgery compared with opioid-naïve patients. Rates of hospital admissions and postoperative emergency department encounters were higher in all opioid use groups. Adjusted differences in 6-month preoperative and 3-month postoperative health care costs were seen in the opioid use groups compared with opioid-naïve patients, ranging from US$1307 to US$5820 ( < .001).
Preoperative opioid use was a risk factor for complications and revision surgery after arthroscopic RCR. We also observed a dose-dependent response between opioid use and postoperative complications.
研究表明,术前使用阿片类药物会影响各种手术的术后结果。研究人员尚未评估其在肩袖修复(RCR)术后的相关性。
假设/目的:本研究旨在评估关节镜 RCR 术后术前使用阿片类药物与结果之间的关系。我们假设,接受较高日平均术前口服吗啡等效物(OME)处方的患者,90 天并发症和 3 年翻修手术的发生率会增加。
队列研究;证据水平,3 级。
利用 MarketScan 理赔数据库,确定 2009 年至 2018 年间接受关节镜 RCR 的患者。我们根据术前 6 个月内消耗的平均每日 OME 将患者分为以下几组:阿片类药物未使用者、<1、1-<5、5-<10 和≥10 OME/天。我们检索了 90 天并发症和 3 年翻修手术的发生率。然后,将阿片类药物使用组与二项逻辑回归和广义线性模型进行比较。
我们确定了 214283 名患者。其中,50.7%的患者未接受任何术前阿片类药物治疗,而分别有 7.7%、26.8%、6.3%和 8.6%的患者在 6 个月的时间内接受了<1、1-<5、5-<10 和≥10 OME/天的治疗。随着术前 OME 的增加,并发症的发生率也随之增加。多变量分析显示,每天使用≥1 OME 的任何患者,3 年翻修手术、再次手术和感染的发生率均增加。具体而言,与阿片类药物未使用者相比,平均每天使用≥10 OME 的患者,翻修手术的几率增加了 103%(比值比,2.03[95%CI,1.62-2.54];<0.001)。在所有阿片类药物使用组中,住院和术后急诊就诊的发生率均较高。与阿片类药物未使用者相比,在阿片类药物使用组中观察到 6 个月术前和 3 个月术后医疗保健费用的调整差异,范围为 1307 美元至 5820 美元(<0.001)。
术前使用阿片类药物是关节镜 RCR 后并发症和翻修手术的危险因素。我们还观察到阿片类药物使用与术后并发症之间存在剂量依赖性关系。